Fig. 2
From: Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
Boxplot of metabolites that belong to the enriched pathways associated with increased risk of obesity-associated insulin resistance and T2DM. Linear regression was performed to identify significant metabolites associated with disease progression using the R statistical package after correcting for age, gender, BMI and principle components (PC1 and PC2). Y-axis indicates levels of metabolites (log2). A p-value significance level of 0.05 was used